Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 6/2011

Ausgabe 6/2011

Inhaltsverzeichnis ( 38 Artikel )

01.12.2011 | Editorial | Ausgabe 6/2011

Breast cancer: current state and future promise

Lewis A Chodosh

01.12.2011 | Review | Ausgabe 6/2011

Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity

David J Drasin, Tyler P Robin, Heide L Ford

01.12.2011 | Review | Ausgabe 6/2011

The microenvironment in breast cancer progression: biology and implications for treatment

Andrew E Place, Sung Jin Huh, Kornelia Polyak

01.12.2011 | Review | Ausgabe 6/2011

Epigenetics in breast cancer: what's new?

Yi Huang, Shweta Nayak, Rachel Jankowitz, Nancy E Davidson, Steffi Oesterreich

01.12.2011 | Review | Ausgabe 6/2011

Clinical relevance and biology of circulating tumor cells

Natalia Bednarz-Knoll, Catherine Alix-Panabières, Klaus Pantel

01.12.2011 | Review | Ausgabe 6/2011

Mammographic density and breast cancer risk: current understanding and future prospects

Norman F Boyd, Lisa J Martin, Martin J Yaffe, Salomon Minkin

01.12.2011 | Review | Ausgabe 6/2011

Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer

Todd W Miller, Brent N Rexer, Joan T Garrett, Carlos L Arteaga

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, Benjamin Esterni, Daniel Serin, Pierre Kerbrat, Fabrice Andre, Pascal Finetti, Emmanuelle Charafe-Jauffret, Anne-Laure Martin, Mario Campone, Patrice Viens, Daniel Birnbaum, Frédérique Penault-Llorca, François Bertucci

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

Arindam Banerjee, Zheng-Sheng Wu, PengXu Qian, Jian Kang, Vijay Pandey, Dong-Xu Liu, Tao Zhu, Peter E Lobie

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth

Takashi Nishioka, Hyun-Seok Kim, Ling-Yu Luo, Yi Huang, Jinjin Guo, Chang Yan Chen

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion

Bernadette C Victor, Arulselvi Anbalagan, Mona M Mohamed, Bonnie F Sloane, Dora Cavallo-Medved

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis

Xiaohui Bi, Meera Hameed, Neena Mirani, Erica Maria Pimenta, Jason Anari, Betsy J Barnes

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance

H Raza Ali, Sarah-Jane Dawson, Fiona M Blows, Elena Provenzano, Paul D Pharoah, Carlos Caldas

01.12.2011 | Viewpoint | Ausgabe 6/2011

Cancer's sweet tooth for serine

Ji Luo

01.12.2011 | Viewpoint | Ausgabe 6/2011

New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours

Richard D Iggo

01.12.2011 | Review | Ausgabe 6/2011

Luminal-B breast cancer and novel therapeutic targets

Ben Tran, Philippe L Bedard

01.12.2011 | Review | Ausgabe 6/2011

'Omic approaches to preventing or managing metastatic breast cancer

Obi L Griffith, Joe W Gray

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study

Sharon N Teraoka, Jonine L Bernstein, Anne S Reiner, Robert W Haile, Leslie Bernstein, Charles F Lynch, Kathleen E Malone, Marilyn Stovall, Marinela Capanu, Xiaolin Liang, Susan A Smith, Josyf Mychaleckyj, Xuanlin Hou, Lene Mellemkjaer, John D Boice Jr, Ashley Siniard, David Duggan, Duncan C Thomas, The WECARE Study Collaborative Group, and Patrick Concannon

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

CHEK2 contribution to hereditary breast cancer in non-BRCAfamilies

Alexis Desrichard, Yannick Bidet, Nancy Uhrhammer, Yves-Jean Bignon

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

Shinichiro Kashiwagi, Masakazu Yashiro, Tsutomu Takashima, Naoki Aomatsu, Katsumi Ikeda, Yoshinari Ogawa, Tetsuro Ishikawa, Kosei Hirakawa

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases

Barbara Adamo, Allison M Deal, Emily Burrows, Joseph Geradts, Erika Hamilton, Kimberly L Blackwell, Chad Livasy, Karen Fritchie, Aleix Prat, J Chuck Harrell, Matthew G Ewend, Lisa A Carey, C Ryan Miller, Carey K Anders

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis

Lorena Hernandez, Marco AO Magalhaes, Salvatore J Coniglio, John S Condeelis, Jeffrey E Segall

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

Nathan R West, Katy Milne, Pauline T Truong, Nicol Macpherson, Brad H Nelson, Peter H Watson

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

Jeffrey L Nordstrom, Sergey Gorlatov, Wenjun Zhang, Yinhua Yang, Ling Huang, Steve Burke, Hua Li, Valentina Ciccarone, Tengfei Zhang, Jeffrey Stavenhagen, Scott Koenig, Stanford J Stewart, Paul A Moore, Syd Johnson, Ezio Bonvini

01.12.2011 | Review | Ausgabe 6/2011

β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer

Hicham Lahlou, William J Muller

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2

Nyam-Osor Chimge, Sanjeev K Baniwal, Gillian H Little, Yi-bu Chen, Michael Kahn, Debu Tripathy, Zea Borok, Baruch Frenkel

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Variants on the promoter region of PTEN affect breast cancer progression and patient survival

Tuomas Heikkinen, Dario Greco, Liisa M Pelttari, Johanna Tommiska, Pia Vahteristo, Päivi Heikkilä, Carl Blomqvist, Kristiina Aittomäki, Heli Nevanlinna

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

Teresa Puig, Helena Aguilar, Sílvia Cufí, Glòria Oliveras, Carlos Turrado, Sílvia Ortega-Gutiérrez, Bellinda Benhamú, María Luz López-Rodríguez, Ander Urruticoechea, Ramon Colomer

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion

Narendra V Sankpal, John D Mayfield, Mike W Willman, Timothy P Fleming, William E Gillanders

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Long-term prognosis of breast cancer detected by mammography screening or other methods

Tiina Lehtimäki, Mikael Lundin, Nina Linder, Harri Sihto, Kaija Holli, Taina Turpeenniemi-Hujanen, Vesa Kataja, Jorma Isola, Heikki Joensuu, Johan Lundin

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer

Richa Tiwary, Weiping Yu, Linda A deGraffenried, Bob G Sanders, Kimberly Kline

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

A genome-wide linkage study of mammographic density, a risk factor for breast cancer

Celia MT Greenwood, Andrew D Paterson, Linda Linton, Irene L Andrulis, Carmel Apicella, Apostolos Dimitromanolakis, Valentina Kriukov, Lisa J Martin, Ayesha Salleh, Elena Samiltchuk, Rashmi V Parekh, Melissa C Southey, Esther M John, John L Hopper, Norman F Boyd, Johanna M Rommens

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Mark Robson, Mark Sherman, Amanda B Spurdle, Barbara Wappenschmidt, Andrew Lee, Lesley McGuffog, Sue Healey, Olga M Sinilnikova, Ramunas Janavicius, Thomas vO Hansen, Finn C Nielsen, Bent Ejlertsen, Ana Osorio, Iván Muñoz-Repeto, Mercedes Durán, Javier Godino, Maroulio Pertesi, Javier Benítez, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Elisa Cattaneo, Bernardo Bonanni, Alessandra Viel, Barbara Pasini, Laura Papi, Laura Ottini, Antonella Savarese, Loris Bernard, Paolo Radice, Ute Hamann, Martijn Verheus, Hanne EJ Meijers-Heijboer, Juul Wijnen, Encarna B Gómez García, Marcel R Nelen, C Marleen Kets, Caroline Seynaeve, Madeleine MA Tilanus-Linthorst, Rob B van der Luijt, Theo van Os, Matti Rookus, Debra Frost, J Louise Jones, D Gareth Evans, Fiona Lalloo, Ros Eeles, Louise Izatt, Julian Adlard, Rosemarie Davidson, Jackie Cook, Alan Donaldson, Huw Dorkins, Helen Gregory, Jacqueline Eason, Catherine Houghton, Julian Barwell, Lucy E Side, Emma McCann, Alex Murray, Susan Peock, Andrew K Godwin, Rita K Schmutzler, Kerstin Rhiem, Christoph Engel, Alfons Meindl, Ina Ruehl, Norbert Arnold, Dieter Niederacher, Christian Sutter, Helmut Deissler, Dorothea Gadzicki, Karin Kast, Sabine Preisler-Adams, Raymonda Varon-Mateeva, Ines Schoenbuchner, Britta Fiebig, Wolfram Heinritz, Dieter Schäfer, Heidrun Gevensleben, Virginie Caux-Moncoutier, Marion Fassy-Colcombet, François Cornelis, Sylvie Mazoyer, Mélanie Léoné, Nadia Boutry-Kryza, Agnès Hardouin, Pascaline Berthet, Danièle Muller, Jean-Pierre Fricker, Isabelle Mortemousque, Pascal Pujol, Isabelle Coupier, Marine Lebrun, Caroline Kientz, Michel Longy, Nicolas Sevenet, Dominique Stoppa-Lyonnet, Claudine Isaacs, Trinidad Caldes, Miguel de la Hoya, Tuomas Heikkinen, Kristiina Aittomäki, Ignacio Blanco, Conxi Lazaro, Rosa B Barkardottir, Penny Soucy, Martine Dumont, Jacques Simard, Marco Montagna, Silvia Tognazzo, Emma D'Andrea, Stephen Fox, Max Yan, Tim Rebbeck, Olufunmilayo I Olopade, Jeffrey N Weitzel, Henry T Lynch, Patricia A Ganz, Gail E Tomlinson, Xianshu Wang, Zachary Fredericksen, Vernon S Pankratz, Noralane M Lindor, Csilla Szabo, Kenneth Offit, Rita Sakr, Mia Gaudet, Jasmine Bhatia, Noah Kauff, Christian F Singer, Muy-Kheng Tea, Daphne Gschwantler-Kaulich, Anneliese Fink-Retter, Phuong L Mai, Mark H Greene, Evgeny Imyanitov, Frances P O'Malley, Hilmi Ozcelik, Gordon Glendon, Amanda E Toland, Anne-Marie Gerdes, Mads Thomassen, Torben A Kruse, Uffe Birk Jensen, Anne-Bine Skytte, Maria A Caligo, Maria Soller, Karin Henriksson, von Anna Wachenfeldt, Brita Arver, Marie Stenmark-Askmalm, Per Karlsson, Yuan Chun Ding, Susan L Neuhausen, Mary Beattie, Paul DP Pharoah, Kirsten B Moysich, Katherine L Nathanson, Beth Y Karlan, Jenny Gross, Esther M John, Mary B Daly, Saundra M Buys, Melissa C Southey, John L Hopper, Mary Beth Terry, Wendy Chung, Alexander F Miron, David Goldgar, Georgia Chenevix-Trench, Douglas F Easton, Irene L Andrulis, Antonis C Antoniou, Breast Cancer Family Registry, EMBRACE, GEMO Study Collaborators, HEBON, kConFab Investigators, Ontario Cancer Genetics Network, SWE-BRCA, CIMBA

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies

Elena Muraro, Debora Martorelli, Elisa Turchet, Gianmaria Miolo, Simona Scalone, Elisa Comaro, Renato Talamini, Katy Mastorci, Davide Lombardi, Tiziana Perin, Antonino Carbone, Andrea Veronesi, Diana Crivellari, Riccardo Dolcetti

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells

Yee-Ming Lee, Jen-Yi Lee, Chao-Chi Ho, Qi-Sheng Hong, Sung-Liang Yu, Chii-Ruey Tzeng, Pan-Chyr Yang, Huei-Wen Chen

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

Johan Staaf, Göran Jönsson, Markus Ringnér, Bo Baldetorp, Åke Borg

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

William Jacot, Evelyne Lopez-Crapez, Simon Thezenas, Romain Senal, Frédéric Fina, Frédéric Bibeau, Gilles Romieu, Pierre-Jean Lamy

01.12.2011 | Research article | Ausgabe 6/2011 Open Access

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation

Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin M Ward, Xiaoyong Fu, Maria F Botero, Nuala A Healy, Susan G Hilsenbeck, Gail Lewis Phillips, Gary C Chamness, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise